Ascendis Pharma (ASND) Receives Positive CHMP Opinion for TransCon CNP in Europe

gurufocus.com · 2026-10-16

On October 16, 2026, Ascendis Pharma (NASDAQ: ASND) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (E

Read the full story at gurufocus.com →